Business
Enzolytics, Inc. Announces Production and Sale in North America of “Enzolytics IPF Immune(TM)”, A New Dietary Supplement That Enhances the Immune System
Enzolytics, Inc. Announces Production and Sale in North America of “Enzolytics IPF Immune(TM)”, A New Dietary Supplement That Enhances the Immune System.
About this update from Enzolytics Inc.
[{"type":"text","content":"COLLEGE STATION, TX / ACCESSWIRE / January 4, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces production and sale in the U.S. and North America of "Enzolytics IPF Immune™," a science-backed liquid nutritional supplement that acts to strengthen the body's immune system. The immune modulator benefits the immune system by fortifying it against infections. The active components in the supplement have been registered with the FDA for use in the U.S. under NDI Reg. No. 1083, and the immune booster is being produced and sold pursuant to the Company's exclusive North America license under U.S. Patent No. 8,309,072 (the ‘072 Patent).In addition to announcing these plans to begin the production of Enzolytics IPF Immune™, the Company has engaged a national marketing and branding agency as its distributor to advance the product through multiple distribution channels throughout the U.S. The Company will significantly benefit from the extensive capacity of the agency to place this product in major outlets, large and small, throughout the country. In addition, the marketing agency's long-stating presence and capability in the industry is a significant benefit to the Company.In the current ongoing pandemic, consumers are seeking any advantage for staying healthy. The CoronaVirus has forced many to reevaluate their health regimen. According to Grand View Research, the North American dietary supplements market was $50.11 Billion in 2020, and the revenue forecast in 2028 is estimated at $77.1 Billion. This year-over-year increase has led to record sales of immunity-enhancing supplements. In 2020, immunity-boosting supplements had record sales, making up one-third of all new supplements sales.The increasing consumer awareness regarding personal health and wellbeing is one of the key drivers of the market. One in four consumers in the U.S. started taking an immune supplement during the COVID-19 pandemic. Now, consumers will soon have Enzolytics IPF Immune™, a science-backed immune modulator supplement.The new product is produced under license to the ‘072 Patent, entitled "Irreversibly-Inactivated Pepsinogen Fragments for Modulating Immune Function", a patent invented by the Company's Chief Scientific Officer Harry Zhabilov.This technology covers the use of Irreversibly Ina...